ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: TH-PO942

Adiponectin and Its Receptors in Peripheral Muscle and Fat Tissues of CKD Patients

Session Information

Category: CKD (Non-Dialysis)

  • 1903 CKD (Non-Dialysis): Mechanisms


  • Milanesi, Samantha, University of Genoa, Genoa, Italy
  • Verzola, Daniela, University of Genoa, Genoa, Italy
  • Saio, Michela, University of Genoa, Genoa, Italy
  • Picciotto, Daniela, University of Genoa, Genoa, Italy
  • Brunori, Giuliano, Ospedale S. Chiara, Trento - Italy, Trento TN, Italy
  • Venturelli, Chiara, APSS TRENTO, Trento, Italy
  • Garibotto, Giacomo, University of Genoa, Genoa, Italy

Inflammation contributes to protein-energy wasting (PEW) in CKD, but the role of adiponectin (APN), which has anti-inflammatory properties, is not known. APN is secreted preferentially by adipocytes, but also by skeletal muscle. APN binds two receptor isoforms, adiponectin receptor 1 (AR1) and adiponectin receptor 2 (AR2). The aim of this study was to examine the expression of APN and its receptors in skeletal muscle and adipose tissue in CKD patients.


Muscle biopsies were obtained from 29 CKD (eGFR 8±3 ml/min per 1.73m2 , 15M/14F, age 69 yrs) patients and 14 controls (C) rectus abdominis muscle samples. In this cohort, visceral fat samples were also obtained in 16 CKD and 10 C subjects. The expressions of APN, AR1 and R2 were tested by rtPCR and immunohistochemistry.


Skeletal Muscle: APN gene expression and protein were up-regulated, (by 6-3.5 folds with respect to C, p< 0.001), AR1 and R2 mRNAs were markedly downregulated (-90 %, p<0,001), while protein expression was unchanged in CKD vs. C. Adipose tissue: APN, AR1 and R2 mRNAs were upregulate (by 2-7 folds, p<0.05) in CKD vs. C. Muscle APN mRNA was directly related to TLR4 protein expression (r2=0.33, p=0.023); moreover, APN and IL-6 protein were directly related (r2=0.28, p<0.01). Only as a trend, APN protein was related to NF-kB pp65 (r2=0.179, p=0.056). Visceral Fat APN was directly related to plasma CRP ( r=0.62, p=0.028).


In conclusion, muscle and visceral fat APN and APN receptors expression pattern is markedly modified in CKD. The APN system appears to respond to chronic inflammation as a compensatory mechanism which helps to maintain body homeostasis.